Response to ²²⁵Ac-PSMA-I&T after failure of long-term ¹⁷⁷Lu-PSMA RLT in mCRPC

Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1262-1263. doi: 10.1007/s00259-020-05023-2. Epub 2020 Sep 22.

Authors

Harun Ilhan¹, Astrid Gosewisch², Guido Böning², Friederike Völter², Mathias Zacherl², Marcus Unterrainer³, Peter Bartenstein², Andrei Todica², Franz Josef Gildehaus²

Affiliations

¹ Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. harun.ilhan@med.uni-muenchen.de.
² Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
³ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Dipeptides
Heterocyclic Compounds, 1-Ring
Humans
Male
Prostatic Neoplasms, Castration-Resistant* / radiotherapy

Substances

Dipeptides
Heterocyclic Compounds, 1-Ring